Diabetes and Sexuality

Sexual Medicine Reviews - Tập 5 - Trang 45-51 - 2017
Fuat Kizilay1, Helena Elizabeth Gali2, Ege Can Serefoglu3
1Department of Urology, Turgutlu State Hospital, Manisa, Turkey
2University of California San Diego School of Medicine, San Diego, CA, USA
3Department of Urology, Bagcilar Training and Research Hospital, Istanbul, Turkey

Tài liệu tham khảo

Whiting, 2011, IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030, Diabetes Res Clin Pract, 94, 311, 10.1016/j.diabres.2011.10.029 Singh, 2013, The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis, PLoS One, 8, e65174, 10.1371/journal.pone.0065174 Yale, 2013, Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease, Diabetes Obes Metab, 15, 463, 10.1111/dom.12090 Kawasaki, 2013, Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications Study, Ophthalmology, 120, 574, 10.1016/j.ophtha.2012.08.029 Tesfaye, 1996, Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study, Diabetologia, 39, 1377, 10.1007/s001250050586 Jaiswal, 2013, Peripheral neuropathy in adolescents and young adults with type 1 and type 2 diabetes from the SEARCH for Diabetes in Youth Follow-up Cohort A pilot study, Diabetes Care, 36, 3903, 10.2337/dc13-1213 Sparring, 2013, Diabetes duration and health-related quality of life in individuals with onset of diabetes in the age group 15–34 years—a Swedish population-based study using EQ-5D, BMC Public Health, 13, 377, 10.1186/1471-2458-13-377 Laumann, 2005, Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors, Int J Impot Res, 17, 39, 10.1038/sj.ijir.3901250 Laumann, 1999, Sexual dysfunction in the United States: prevalence and predictors, JAMA, 281, 537, 10.1001/jama.281.6.537 Feldman, 1994, Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study, J Urol, 151, 54 Burke, 2007, Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men, J Urol, 177, 1438 Elyasi, 2015, Sexual dysfunction in women with type 2 diabetes mellitus, Iran J Med Sci, 40, 206 Enzlin, 2009, Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/EDIC study cohort, Diabetes Care, 32, 780, 10.2337/dc08-1164 Abu Ali, 2008, Sexual dysfunction in Jordanian diabetic women, Diabetes Care, 31, 1580, 10.2337/dc08-0081 Binmoammar, 2016, The impact of poor glycaemic control on the prevalence of erectile dysfunction in men with type 2 diabetes mellitus: a systematic review, JRSM Open, 7, 10.1177/2054270415622602 Seftel, 2004, The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction, J Urol, 171, 2341 Esposito, 2005, High proportions of erectile dysfunction in men with the metabolic syndrome, Diabetes Care, 28, 1201, 10.2337/diacare.28.5.1201 Miner, 2012, Cardiometabolic risk and female sexual health: the Princeton III summary, J Sex Med, 9, 641 Esposito, 2009, Hyperlipidemia and sexual function in premenopausal women, J Sex Med, 6, 1696 Esposito, 2005, Sexual dysfunction in women with the metabolic syndrome, Diabetes Care, 28, 756, 10.2337/diacare.28.3.756 1993, Impotence. NIH Consensus Development Panel on Impotence, JAMA, 270, 83, 10.1001/jama.1993.03510010089036 Lewis, 2010, Original articles: definitions/epidemiology/risk factors for sexual dysfunction, J Sex Med, 7, 1598 Johannes, 2000, Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study, J Urol, 163, 460 Yamasaki, 2004, Prevalence and risk factors of erectile dysfunction in Japanese men with type 2 diabetes, Diabetes Res Clin Pract, 66, S173, 10.1016/j.diabres.2003.09.019 Hannula, 2015, Social well-being of young adults with type 1 diabetes since childhood. The Oulu cohort study of diabetic retinopathy, Scand J Public Health, 43, 623, 10.1177/1403494815588423 De Berardis, 2002, Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked, Diabetes Care, 25, 284, 10.2337/diacare.25.2.284 Castela, 2016, Molecular mechanisms associated with diabetic endothelial-erectile dysfunction, Nat Rev Urol, 13, 266, 10.1038/nrurol.2016.23 Guay, 2007, ED 2: erectile dysfunction = endothelial dysfunction, Endocrinol Metab Clin North Am, 36, 453, 10.1016/j.ecl.2007.03.007 Thorve, 2011, Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management, J Diabetes Complications, 25, 129, 10.1016/j.jdiacomp.2010.03.003 Malavige, 2009, Erectile dysfunction in diabetes mellitus, J Sex Med, 6, 1232 Bortolotti, 2001, Cigarette smoking: a risk factor for erectile dysfunction in diabetics, Eur Urol, 40, 392, 10.1159/000049805 Giuliano, 2004, Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both, Urology, 64, 1196, 10.1016/j.urology.2004.08.059 Nehra, 2001, Neurologic erectile dysfunction, Urol Clin North Am, 28, 289, 10.1016/S0094-0143(05)70139-7 Dhindsa, 2004, Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes, J Clin Endocrinol Metab, 89, 5462, 10.1210/jc.2004-0804 Christiansen, 2001, Behavioural effects of androgen in men and women, J Endocrinol, 170, 39, 10.1677/joe.0.1700039 Kapoor, 2007, Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity, Diabetes Care, 30, 911, 10.2337/dc06-1426 Kapoor, 2007, Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes, Int J Androl, 30, 500, 10.1111/j.1365-2605.2007.00744.x Skyler, 2009, J Am Coll Cardiol, 53, 298, 10.1016/j.jacc.2008.10.008 Nathan, 2009, Arch Intern Med, 169, 1307, 10.1001/archinternmed.2009.193 Clarke, 2003, The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65), Diabet Med, 20, 442, 10.1046/j.1464-5491.2003.00972.x Kirilmaz, 2015, The effect of lifestyle modification and glycemic control on the efficiency of sildenafil citrate in patients with erectile dysfunction due to type-2 diabetes mellitus, Aging Male, 18, 244, 10.3109/13685538.2015.1072154 Dorsey, 2010, Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction, Expert Opin Pharmacother, 11, 1109, 10.1517/14656561003698131 Santi, 2016, Six months of daily treatment with vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial, Eur J Endocrinol, 174, 513, 10.1530/EJE-15-1100 Vardi, 2007, Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus, Cochrane Database Syst Rev, 1, CD002187 Francis, 2011, PDE5 inhibitors: targeting erectile dysfunction in diabetics, Curr Opin Pharmacol, 11, 683, 10.1016/j.coph.2011.08.004 Porst, 2006, Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial, Eur Urol, 50, 351, 10.1016/j.eururo.2006.02.052 Vrijhof, 1994, Vacuum constriction devices in erectile dysfunction: acceptance and effectiveness in patients with impotence of organic or mixed aetiology, Br J Urol, 74, 102, 10.1111/j.1464-410X.1994.tb16555.x Gentile, 2016, Patient's satisfaction after 2-piece inflatable penile prosthesis implantation: an Italian multicentric study, Arch Ital Urol Androl, 88, 1, 10.4081/aiua.2016.1.1 1999, The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction, J Urol, 162, 628 Wang, 2008, Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations, Eur J Endocrinol, 159, 507, 10.1530/EJE-08-0601 Jones, 2011, Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study), Diabetes Care, 34, 828, 10.2337/dc10-1233 Hatzimouratidis, 2010, Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation, Eur Urol, 57, 804, 10.1016/j.eururo.2010.02.020 Lei, 2015, Low-intensity pulsed ultrasound improves erectile function in streptozotocin-induced type I diabetic rats, Urology, 86, 1241.e11, 10.1016/j.urology.2015.07.026 Liu, 2015, Hepatocyte growth factor-modified adipose tissue-derived stem cells improve erectile function in streptozotocin-induced diabetic rats, Growth Factors, 33, 282, 10.3109/08977194.2015.1077825 Kutlu, 2016, Antifibrogenic role of valproic acid in streptozotocin induced diabetic rat penis, Andrologia, 48, 453, 10.1111/and.12465 Wang, 2015, Antioxidant acaricide II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats, J Cell Mol Med, 19, 960, 10.1111/jcmm.12480 Wang, 2014, AGE-breaker ALT-711 plus insulin could restore erectile function in streptozocin-induced type 1 diabetic rats, J Sex Med, 11, 1452 Gandhi, 2016, Effect of diabetes mellitus on sexual arousal and intercourse, Transl Biomed, 7, 2, 10.21767/2172-0479.100057 Fedder, 2013, Retrograde ejaculation and sexual dysfunction in men with diabetes mellitus: a prospective, controlled study, Andrology, 1, 602, 10.1111/j.2047-2927.2013.00083.x Malavige, 2008, Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido, J Sex Med, 5, 2125 El-Sakka, 2003, Premature ejaculation in non-insulin-dependent diabetic patients, Int J Androl, 26, 329, 10.1111/j.1365-2605.2003.00433.x Kurbatov, 2015, Correction of retrograde ejaculation in patients with diabetes mellitus using endourethral collagen injection: preliminary results, J Sex Med, 12, 2126 Perelman, 2006, Retarded ejaculation, World J Urol, 24, 645, 10.1007/s00345-006-0127-6 Berman, 2006, Complicated hypertension related to the abuse of ephedrine and caffeine alkaloids, J Addict Dis, 25, 45, 10.1300/J069v25n03_06 Majzoub, 2016, Premature ejaculation in type II diabetes mellitus patients: association with glycemic control, Transl Androl Urol, 5, 248, 10.21037/tau.2016.03.11 Bellastella, 2015, Premature ejaculation is associated with glycemic control in type 1 diabetes, J Sex Med, 12, 93 Corona, 2013, Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction, J Sex Med, 10, 1074 Kalinchenko, 2003, Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone, Aging Male, 6, 94, 10.1080/tam.6.2.94.99 Bhasin, 2010, Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, 95, 2536, 10.1210/jc.2009-2354 2015 Zemishlany, 2008, The impact of mental illness on sexual dysfunction, 89 Latini, 2006, Original research—erectile dysfunction: clinical and psychosocial characteristics of men with erectile dysfunction: baseline data from ExCEED™, J Sex Med, 3, 1059 Marson, 2013, Animal models for the study of female sexual dysfunction, Sex Med Rev, 1, 108, 10.1002/smrj.14 Duby, 2004, Diabetic neuropathy: an intensive review, Am J Health System Pharm, 61, 160, 10.1093/ajhp/61.2.160 Thomas, 1994, Sexual functioning in persons with diabetes: issues in research, treatment, and education, Clin Psychol Rev, 14, 61, 10.1016/0272-7358(94)90048-5 Enzlin, 1998, Diabetes mellitus and female sexuality: a review of 25 years' research, Diabet Med, 15, 809, 10.1002/(SICI)1096-9136(199810)15:10<809::AID-DIA689>3.0.CO;2-Z Copeland, 2012, Diabetes mellitus and sexual function in middle-aged and older women, Obstet Gynecol, 120, 331, 10.1097/AOG.0b013e31825ec5fa Leedom, 1991, Symptoms of sexual dysfunction and depression in diabetic women, J Diabet Complications, 5, 38, 10.1016/0891-6632(91)90009-E Basson, 2005, Women's sexual dysfunction: revised and expanded definitions, CMAJ, 172, 1327, 10.1503/cmaj.1020174 Fugl-Meyer, 1999, Sexual disabilities, problems and satisfaction in 18–74 year old Swedes, Scand J Sexol, 2, 79 Basson, 2010, Reports: summary of the recommendations on sexual dysfunctions in women, J Sex Med, 7, 314 Camacho, 2005, Sexual dysfunction in the elderly: age or disease?, Int J Impot Res, 17, S52, 10.1038/sj.ijir.3901429 Nijland, 2008, Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial, J Sex Med, 5, 646 Rubio-Aurioles, 2002, Phentolamine mesylate in postmenopausal women with female sexual arousal disorder: a psychophysiological study, J Sex Marital Ther, 28, 205, 10.1080/00926230252851339 Sarkadi, 2003, Intimacy and women with type 2 diabetes: an exploratory study using focus group interviews, Diabetes Educ, 29, 641, 10.1177/014572170302900410 Sherwin, 1991, The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women, J Clin Endocrinol Metab, 72, 336, 10.1210/jcem-72-2-336 Dew, 2003, A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer, Climacteric, 6, 45, 10.1080/cmt.6.1.45.52 Buster, 2005, Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial, Obstet Gynecol, 105, 944, 10.1097/01.AOG.0000158103.27672.0d DeRogatis, 2012, Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET study, J Sex Med, 9, 1074 Goldstein, 2014, Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy, Climacteric, 17, 173, 10.3109/13697137.2013.834493 Qu, 2000, Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats 1, Endocrinology, 141, 809, 10.1210/endo.141.2.7342 Simon, 2013, One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus, Menopause, 20, 418, 10.1097/gme.0b013e31826d36ba